18368-73-5

Basic information

• Product Name: 3-Methyl-2-nitropyridine
• Synonyms: 2-NITRO-3-METHYLPYRIDINE;2-NITRO-3-PICOLINE;3-METHYL-2-NITROPYRIDINE;3-Methy-2-nitrolpyridine;Pyridine, 3-methyl-2-nitro- (9CI);2-AMINO-3-PICILINE;3-Methyl-2-nitropyridine ,97%;3-Methyl-2-nitro-pyridin
• CAS NO: 18368-73-5
• Molecular Formula: C₆H₆N₂O₂
• Molecular Weight: 138.12
• EINECS: -0
• Product Categories: NITRO;Pyridines, Pyrimidines, Purines and Pteredines;Pyridine;Pyridines
• Mol File: 18368-73-5.mol
• Article Data: 4

Chemical Properties

• Melting Point: 43-44 °C
• Boiling Point: 266.6 °C at 760 mmHg
• Flash Point: 115 °C
• Appearance: /
• Density: 1.246 g/cm³
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -2.30±0.22(Predicted)
• CAS DataBase Reference: 3-Methyl-2-nitropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Methyl-2-nitropyridine(18368-73-5)
• EPA Substance Registry System: 3-Methyl-2-nitropyridine(18368-73-5)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 18368-73-5(Hazardous Substances Data)

Usage

Chemical Properties

Yellow crystal

Upstream product

• 1603-40-3 3-methylpyridin-2-ylamine 
• 7722-84-1 dihydrogen peroxide 
• 100047-38-9 3-methyl-2-nitro-pyridine-1-oxide 
• 67-66-3 chloroform 
• 7719-12-2 phosphorus trichloride 

Downstream Products

• 1403954-71-1 3-methyl-2-(o-tolyl)pyridine N-oxide 
• 1403954-74-4 2-(2-cyanophenyl)-3-methylpyridine N-oxide 
• 15936-06-8 3-(bromomethyl)-2-nitropyridine 
• 33225-72-8 2-nitronicotinic acid 

Relevant articles and documents

Novel D-amino acid oxidase (DAAO) inhibitor as well as preparation method and application thereof

The invention provides a novel D-amino acid oxidase (DAAO) inhibitor as well as a preparation method and application thereof, and in particular discloses 3-hydroxyl-3,4-dihydroquinazoline-2(1H)-one compounds as shown in a formula A, derivatives of the compounds, a preparation method of the compounds and the derivatives of the compounds, and use of the compounds and the derivatives of the compounds as the DAAO inhibitor. The compounds have good functions of easing pain and blocking tolerance to morphine analgesia, thus having the application value of analgesia, treatment for opium drug tolerance and schizophrenia resistance.

Bicyclic And Tricyclic Compounds As KAT II Inhibitors

Compounds of Formula X: wherein A, X, Y, Z, R5, R6a, and R6b are as defined herein, and pharmaceutically acceptable salts thereof, are described as useful for the treatment of cognitive deficits associated with schizophrenia and other neurodegenerative and/or neurological disorders in mammals, including humans.